Saw Palmetto Trial At Higher Dose Would Be “Logical” – NCCAM’s Miller
This article was originally published in The Tan Sheet
Executive Summary
A dose escalation study is a "very logical next step" for saw palmetto researchers to take, according to Heather Miller, PhD, of NCCAM's Division of Extramural Research & Training